Do adjuvant aromatase inhibitors increas
✍
Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi;
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 203 KB
👁 1 views
## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version